Caldwell Trust Co bought a new position in Procter & Gamble Company (The) (NYSE:PG – Free Report) in the second quarter, according to its most recent disclosure with the SEC. The firm bought 65,627 shares of the company’s stock, valued at approximately $10,456,000. Procter & Gamble comprises approximately 1.0% of Caldwell Trust Co’s portfolio, making the stock its 25th biggest position.
Several other institutional investors and hedge funds have also recently modified their holdings of PG. Kingstone Capital Partners Texas LLC boosted its holdings in Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares during the last quarter. Norges Bank purchased a new stake in shares of Procter & Gamble during the 2nd quarter valued at approximately $5,099,644,000. Laurel Wealth Advisors LLC lifted its holdings in Procter & Gamble by 15,971.7% in the second quarter. Laurel Wealth Advisors LLC now owns 7,012,744 shares of the company’s stock valued at $1,117,270,000 after acquiring an additional 6,969,110 shares during the last quarter. Vanguard Group Inc. grew its position in Procter & Gamble by 1.4% in the second quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company’s stock worth $37,155,222,000 after acquiring an additional 3,189,111 shares during the period. Finally, Invesco Ltd. increased its stake in Procter & Gamble by 21.4% during the second quarter. Invesco Ltd. now owns 16,374,499 shares of the company’s stock worth $2,608,785,000 after acquiring an additional 2,880,895 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Trading Up 1.4%
Shares of PG stock opened at $142.77 on Monday. Procter & Gamble Company has a fifty-two week low of $138.14 and a fifty-two week high of $179.99. The company has a 50 day moving average price of $147.84 and a 200 day moving average price of $154.16. The stock has a market capitalization of $333.61 billion, a P/E ratio of 20.84, a price-to-earnings-growth ratio of 4.80 and a beta of 0.39. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Friday, October 24th were issued a dividend of $1.0568 per share. The ex-dividend date was Friday, October 24th. This represents a $4.23 annualized dividend and a yield of 3.0%. Procter & Gamble’s dividend payout ratio is 61.75%.
Insider Buying and Selling
In related news, COO Shailesh Jejurikar sold 3,986 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the completion of the transaction, the chief operating officer owned 46,899 shares in the company, valued at $7,139,434.77. The trade was a 7.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Susan Street Whaley sold 2,408 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $366,569.84. Following the transaction, the insider owned 31,770 shares of the company’s stock, valued at $4,836,347.10. This trade represents a 7.05% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 30,308 shares of company stock worth $4,611,852 over the last ninety days. Company insiders own 0.20% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts have recently commented on PG shares. Wells Fargo & Company decreased their price target on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research note on Thursday, September 25th. UBS Group decreased their target price on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Dbs Bank raised shares of Procter & Gamble to a “hold” rating in a research note on Friday, December 5th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Procter & Gamble from $176.00 to $171.00 and set a “buy” rating on the stock in a research note on Monday, December 8th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Procter & Gamble in a research report on Monday, December 1st. Twelve equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $171.40.
Get Our Latest Stock Report on PG
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Dave & Buster’s Reversal Is in PLAY After Double-Bottom Breakout
- What Are Trending Stocks? Trending Stocks Explained
- 3 Finance Stocks to Buy on Rising 10-Year Treasury Rates
- Using the MarketBeat Dividend Tax Calculator
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
